Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick

    Editors Pick - Page 59

    KIMS Hospitals gets over Rs 890 crore investment from General Atlantic

    KIMS Hospitals gets over Rs 890 crore investment from General Atlantic

    Ruby Khatun Khatun29 Jun 2018 12:24 PM IST
    Hyderabad: Krishna Institute of Medical Sciences (KIMS Hospitals), a leading multi-disciplinary provider of healthcare services in Andhra Pradesh and...
    Pfizer abusing market power, alleges Australian watchdog

    Pfizer abusing market power, alleges Australian watchdog

    Ruby Khatun Khatun28 Jun 2018 10:42 AM IST
    MELBOURNE: Australia’s competition watchdog said it would appeal to the nation’s high court for a ruling on whether Pfizer Inc used its market power...
    Oxytocin manufacture banned from 1st July 2018, only this one firm will manufacture it

    Oxytocin manufacture banned from 1st July 2018, only this one firm will manufacture it

    Ruby Khatun Khatun27 Jun 2018 5:23 PM IST
    KAPL to manufacture the drug for domestic use onlyThe Ministry of Health and Family Welfare has restricted the manufacture of Oxytocin formulations...
    Over Rs 460 crore support by govt for development of pharma sector

    Over Rs 460 crore support by govt for development of pharma sector

    Ruby Khatun Khatun26 Jun 2018 3:24 PM IST
    New Delhi: The government has proposed over Rs 460 crore support for the development of pharmaceuticals industry with an aim to reduce the cost of...
    Biocon receives EIR from USFDA for its Bengaluru facility producing sterile

    Biocon receives EIR from USFDA for its Bengaluru facility producing sterile

    Ruby Khatun Khatun25 Jun 2018 3:04 PM IST
    New Delhi: Biotechnology firm Biocon said it has received Establishment Inspection Report (EIR) from the US health regulator on the closure of...
    Shocking: Sensitive medical data of Andhra Pradesh residents on the web

    Shocking: Sensitive medical data of Andhra Pradesh residents on the web

    Ruby Khatun Khatun24 Jun 2018 9:30 AM IST
    HYDERABAD: Shocking!!! Sensitive medical details of patients who bought medicines from government supported generic medicine stores have been uploaded...
    Fighting Malaria: Strides Shasun gets WHO pre-qualification for rectal artesunate product

    Fighting Malaria: Strides Shasun gets WHO pre-qualification for rectal artesunate product

    Ruby Khatun Khatun23 Jun 2018 4:05 PM IST
    New Delhi: Drug firm Strides Shasun said it has received pre-qualification from the World Health Organization (WHO) for its rectal artesunate product...
    Sebi will act against pharma cos in case of non-disclosure of material information, says Tyagi

    Sebi will act against pharma cos in case of non-disclosure of material information, says Tyagi

    Ruby Khatun Khatun22 Jun 2018 3:09 PM IST
    Mumbai: Markets regulator Sebi said it would take action against pharma companies if they are found not sharing information on material events like...
    Spurious Drugs Issue: DCGI Invites Top Pharma Brands on 25th June

    Spurious Drugs Issue: DCGI Invites Top Pharma Brands on 25th June

    Ruby Khatun Khatun21 Jun 2018 5:17 PM IST
    New Delhi: Through a recent notification, the Drug Controller General of India has invited manufacturers for a meeting on the introduction of trace...
    Cipla gets USFDA nod for generic HIV drug

    Cipla gets USFDA nod for generic HIV drug

    Ruby Khatun Khatun21 Jun 2018 3:23 PM IST
    New Delhi: Drug major Cipla said it has received approval from the US health regulator to market Efavirenz tablets, used to treat HIV-1 infections in...
    Marketing of unapproved drugs: Amendment in Act aimed to hold Pharma Giants Responsible

    Marketing of unapproved drugs: Amendment in Act aimed to hold Pharma Giants Responsible

    Ruby Khatun Khatun20 Jun 2018 4:25 PM IST
    New Delhi: Pharmaceutical companies, including the big ones are now under the radar of the central government which is planning to crack down on all...
    Government to study ways for boosting pharma export to China

    Government to study ways for boosting pharma export to China

    Ruby Khatun Khatun19 Jun 2018 10:15 AM IST
    New Delhi: The commerce ministry has commissioned a study on ways to boost the export of pharmaceutical products to China.The study aims to have a...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    French court dismisses damage claims against Merck over Levothyrox

    French court dismisses damage claims against Merck over Levothyrox

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    German drug assessment body not convinced by Bayers cancer drug Vitrakvi

    German drug assessment body not convinced by Bayer's cancer drug Vitrakvi

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok